BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $218,147 | -43.2% | 4,280 | -40.0% | 0.12% | -36.3% |
| Q3 2022 | $384,000 | 0.0% | 7,130 | +19.2% | 0.19% | +11.6% |
| Q2 2022 | $384,000 | -4.5% | 5,982 | +15.3% | 0.17% | +3.0% |
| Q1 2022 | $402,000 | -9.7% | 5,186 | 0.0% | 0.17% | -4.5% |
| Q4 2021 | $445,000 | +1.8% | 5,186 | -4.6% | 0.18% | -2.2% |
| Q3 2021 | $437,000 | +24.5% | 5,435 | +24.7% | 0.18% | +25.9% |
| Q2 2021 | $351,000 | +0.3% | 4,360 | +0.0% | 0.14% | -12.3% |
| Q1 2021 | $350,000 | 0.0% | 4,359 | 0.0% | 0.16% | 0.0% |
| Q4 2020 | $350,000 | +27.3% | 4,359 | +27.5% | 0.16% | +5.2% |
| Q3 2020 | $275,000 | -6.5% | 3,419 | 0.0% | 0.16% | -10.9% |
| Q2 2020 | $294,000 | +3.9% | 3,419 | -1.9% | 0.17% | -13.4% |
| Q1 2020 | $283,000 | -11.8% | 3,486 | -9.1% | 0.20% | +9.8% |
| Q4 2019 | $321,000 | +5.2% | 3,836 | +10.0% | 0.18% | +4.0% |
| Q3 2019 | $305,000 | +14.7% | 3,486 | +7.5% | 0.18% | +16.6% |
| Q2 2019 | $266,000 | -24.6% | 3,243 | -25.3% | 0.15% | -29.4% |
| Q1 2019 | $353,000 | +69.7% | 4,343 | +37.2% | 0.21% | +37.2% |
| Q4 2018 | $208,000 | -14.8% | 3,166 | 0.0% | 0.16% | -4.9% |
| Q3 2018 | $244,000 | -6.5% | 3,166 | -10.6% | 0.16% | -9.9% |
| Q2 2018 | $261,000 | +13.5% | 3,540 | +0.0% | 0.18% | +7.1% |
| Q1 2018 | $230,000 | – | 3,539 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |